EmbryoNet: using deep learning to link embryonic phenotypes to signaling pathways.

Journal: Nature methods
PMID:

Abstract

Evolutionarily conserved signaling pathways are essential for early embryogenesis, and reducing or abolishing their activity leads to characteristic developmental defects. Classification of phenotypic defects can identify the underlying signaling mechanisms, but this requires expert knowledge and the classification schemes have not been standardized. Here we use a machine learning approach for automated phenotyping to train a deep convolutional neural network, EmbryoNet, to accurately identify zebrafish signaling mutants in an unbiased manner. Combined with a model of time-dependent developmental trajectories, this approach identifies and classifies with high precision phenotypic defects caused by loss of function of the seven major signaling pathways relevant for vertebrate development. Our classification algorithms have wide applications in developmental biology and robustly identify signaling defects in evolutionarily distant species. Furthermore, using automated phenotyping in high-throughput drug screens, we show that EmbryoNet can resolve the mechanism of action of pharmaceutical substances. As part of this work, we freely provide more than 2 million images that were used to train and test EmbryoNet.

Authors

  • Daniel Čapek
    Systems Biology of Development, University of Konstanz, Konstanz, Germany.
  • Matvey Safroshkin
    Computer Vision Studio, Tübingen, Germany.
  • Hernán Morales-Navarrete
    Systems Biology of Development, University of Konstanz, Konstanz, Germany.
  • Nikan Toulany
    Systems Biology of Development, University of Konstanz, Konstanz, Germany.
  • Grigory Arutyunov
    Computer Vision Studio, Tübingen, Germany.
  • Anica Kurzbach
    Systems Biology of Development, University of Konstanz, Konstanz, Germany.
  • Johanna Bihler
    Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.
  • Julia Hagauer
    Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.
  • Sebastian Kick
    Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.
  • Felicity Jones
    Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.
  • Ben Jordan
    Systems Biology of Development, University of Konstanz, Konstanz, Germany.
  • Patrick Müller
    Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University Düsseldorf, Duesseldorf, Germany.